Iovance stock drops nearly 10% following snag with FDA over experimental melanoma treatment
October 06, 2020 at 14:05 PM EDT
The California biotech company is building a cell therapy production plant at the Philadelphia Navy Yard.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.